About us > Our History
Our History
Seqalis™ is a trademark of BIO.be S.A. since June 2022. This underlines an important milestone in the history of the company. The name embodies the concepts of Service, Quality Assurance and Life Sciences.
This change emphasises our strong willingness to further reinforce our unique expertise and analytical service offering in Anatomical Pathology, Cytogenetics and Molecular Biology through technological and scientific advances in the Life Sciences markets. With our clients, we aim to speed up scientific progress through innovative ideas and paradigm shifts by adapting our technologies to make this step achievable.
The launch of our quantitative TCR sequencing platform for monitoring the immune response of patients in the rapidly growing field of personalised medicine is one of numerous examples.
Seqalis™ will also keep on intensively cross-pollinating with its mother company, the Institute of Pathology and Genetics (IPG), one of the eight Belgian Genetics Centres, to continuously foster innovation in the medical and diagnostic fields.
1958
Creation of the Institute of Pathology and Genetics (IPG)
1968
Creation of the IPG Human Genetics Centre
2000
Creation of the forensic laboratory (stopped in 2016)
2003
Creation of BIO.be
2006
Move to the Gosselies facility (10,000 m2)
2009
Creation of a biobank for human biological samples
2012
Shareholding in OncoDNA S.A.
2013
Launch of a services portfolio in Molecular Biology, Anatomic-Pathology and Cytogenetics
2021
NGS services (WES, RNAseq, WGS)
2022
Creation of Seqalis™
Launch of Immune Monitoring services